Astrazeneca Earnings Preview: Can This Streak Continue?
Astrazeneca (NYSE:AZN) will report earnings before markets open on Thursday, April 25th. AstraZeneca PLC is a holding company. Through its subsidiaries, the Group researches, manufactures and sells pharmaceutical and medical products. The Group focuses its operations on seven therapeutic areas: Gastrointestinal, Oncology, Cardiovascular, Respiratory, Central Nervous System, Pain Control, Anaesthesia and Infection.
Here is your Cheat Sheet to Astrazeneca Earnings:
Earnings Expectations: Analysts expect earnings of $1.33 per share on revenues of $6.53 billion. Currently, the company’s P/E ratio stands at 10.25.
Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $1.39 to a profit $1.21. For the current year, the average estimate is a profit of $5.38, which is worse than the estimate ninety days ago.
Here’s how Astrazeneca has been performing on an annual basis:
|Revenue ($) in millions||31,600||32,800||33,270||33,590||27,970|
|Diluted EPS ($)||4.20||5.19||5.57||7.30||4.98|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Dec. 31, 2011||Mar. 31, 2012||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012|
|Revenue ($) in millions||8,656||7,349||6,660||6,682||7,282|
|Diluted EPS ($)||1.16||1.28||1.27||1.21||1.22|
Astrazeneca has beat analyst estimates 4 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)